Total Payments
$2,140
2024 Payments
$457.20
Companies
20
Transactions
111
Medicare Patients
1,276
Medicare Billing
$86,249
Payment Breakdown by Category
Food & Beverage$2,140 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,140 | 111 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $460.24 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $339.97 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $290.22 | 15 | $0 (2022) |
| PFIZER INC. | $160.80 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $149.00 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $145.43 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $109.13 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $92.57 | 5 | $0 (2022) |
| Esperion Therapeutics, Inc. | $83.36 | 4 | $0 (2021) |
| Philips Electronics North America Corporation | $64.98 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $457.20 | 27 | Amgen Inc. ($90.35) |
| 2023 | $487.21 | 27 | Boehringer Ingelheim Pharmaceuticals, Inc. ($161.24) |
| 2022 | $367.66 | 21 | Janssen Pharmaceuticals, Inc ($94.52) |
| 2021 | $827.73 | 36 | Janssen Pharmaceuticals, Inc ($195.70) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.66 | General |
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: DIABETES | ||||||
| 06/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: DIABETES | ||||||
| 04/18/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| Category: Medical Device | ||||||
| 04/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiology | ||||||
| 03/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Cardiology | ||||||
| 03/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology | ||||||
| 02/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 225 | 268 | $56,624 | $14,822 |
| 2022 | 3 | 232 | 272 | $57,959 | $12,963 |
| 2021 | 4 | 459 | 554 | $114,531 | $31,998 |
| 2020 | 3 | 360 | 463 | $91,024 | $26,466 |
Total Patients
1,276
Total Services
1,557
Medicare Billing
$86,249
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 181 | $45,731 | $14,074 | 30.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 86 | 87 | $10,893 | $747.34 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 134 | $32,674 | $8,787 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $12,663 | $3,431 | 27.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 98 | 105 | $12,622 | $744.62 | 5.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 249 | 327 | $75,988 | $24,533 | 32.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $16,023 | $4,693 | 29.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 140 | 157 | $18,209 | $1,394 | 7.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 27 | $4,311 | $1,378 | 32.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 265 | 365 | $80,980 | $24,459 | 30.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 21 | 22 | $1,562 | $1,225 | 78.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 74 | 76 | $8,482 | $782.82 | 9.2% |
About Beth Britt
Beth Britt is a Nurse Practitioner healthcare provider based in Bad Axe, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2018. The National Provider Identifier (NPI) number assigned to this provider is 1366912321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Britt has received a total of $2,140 in payments from pharmaceutical and medical device companies, with $457.20 received in 2024. These payments were reported across 111 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,140).
As a Medicare-enrolled provider, Britt has provided services to 1,276 Medicare beneficiaries, totaling 1,557 services with total Medicare billing of $86,249. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Bad Axe, MI
- Active Since 12/03/2018
- Last Updated 12/03/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1366912321
Products in Payments
- Repatha (Biological) $460.24
- JARDIANCE (Drug) $339.97
- XARELTO (Drug) $290.22
- ELIQUIS (Drug) $160.80
- LifeVest (Device) $149.00
- ENTRESTO (Drug) $117.27
- FARXIGA (Drug) $109.13
- Vascepa (Drug) $92.57
- NEXLETOL (Drug) $83.36
- (5044) MCOT (Device) $78.58
- NORTHERA (Drug) $53.41
- Kerendia (Drug) $39.23
- LEQVIO (Drug) $28.16
- Edarbi (Drug) $23.41
- Wegovy (Drug) $19.08
- FUROSCIX (Drug) $16.07
- Assure WCD (Device) $15.51
- Hillrom - Carnation Ambulatory Monitor (Device) $14.84
- (CK4) MCOT (Device) $14.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.